SEOUL, South Korea, May 21, 2026 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision ...

Squamous cell carcinoma of the head and neck (HNSCC) represents a biologically and clinically heterogeneous group of malignancies with significant global ...

A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key ...

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses ...

A new review article brings attention to the critical role of DNA methylation heterogeneity in shaping the tumor microenvironment, highlighting its growing importance in understanding cancer ...

Highlighted research being presented at the 2026 ASCO Annual Meeting includes breast, colorectal, lung, endometrial and renal ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik’s artificial intelligence-based TARIO-2 model identified spatial tumor ...

Current research investigates novel biomarkers that can predict therapeutic outcomes. Finding ways to determine therapeutic efficacy before treating patients would have life-saving outcomes. Many ...

Integrated analysis of systemic inflammation and tumor immune features identifies biologically distinct patient subgroups with differential survival outcomes, outperforming conventional biomarkers ...

Gastric cancer remains a leading cause of cancer-related mortality worldwide, owing in part to late diagnosis and heterogeneous clinical behaviour. Prognostic biomarkers that accurately stratify ...

SUNNYVALE, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, announced positive preliminary Phase 2 ...